Alternatives to Owkin

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

Causal AI drug discovery pairing 20+ petabytes of cellular data with human genetics to find true disease targets

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Recursion runs AI drug discovery as a lab-in-the-loop engine — automated cellular imaging at scale feeding generative chemistry and a clinical pipeline.

AI drug discovery engine pairing 2M weekly automated lab experiments with a 50+ PB proprietary dataset.

AI patient identification for clinical trials: HealthKey scans your EHR daily and emails your team trial-eligible patients.

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

PicnicAI turns patient health records into clinical research data and real-world evidence.

Frekils runs end-to-end real-world evidence studies on your clinical data, with AI writing the statistical code and your patient records never leaving your

Recursion OS pairs automated wet labs with AI models for AI drug discovery at up to 2 million weekly experiments.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Oncology real-world evidence platform combining high-fidelity patient data with AI-assisted cancer research insights.

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

Physics-based molecular simulation with AI for drug discovery and materials design.

PathAI delivers FDA-cleared AISight Dx digital pathology and AI biomarker algorithms for labs and biopharma trials.

Dotmatics Luma Agent: agentic AI for regulated R&D that plans, executes, and documents scientific data analysis

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

AI evidence assembly and quantitative modeling for clinical pharmacology — MBMA databases, Project Optimus dose work, exposure-response

Lamin is a lineage-native open data platform and LaminDB library for traceable, multimodal biotech data — query, govern, and version

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.

Silico is Goodfire's interpretability agent for understanding and debugging the internals of your AI models.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Benchling unifies ELN, LIMS, and AI agents for biotech R&D in one cloud platform.

Tempus pairs tumor DNA/RNA sequencing with AI precision oncology analytics to surface treatment and trial matches

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days

Novaflow is an AI data analyst that turns raw biology data into publication-ready figures and methods, no terminal required.

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and